TipRanks
Go Ultimate55% OFF

Innovent Biologics (1801N) Balance Sheet

Innovent Biologics Balance Sheet

Innovent Biologics's total assets for Q2 2026 were $41.61B, an increase of 11.36% from the previous quarter. MX:1801N total liabilities were $20.87B for the fiscal quarter, a 21.33% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 37.36B$ 21.60B$ 20.63B$ 17.59B$ 16.24B
$ 17.20B$ 8.48B$ 8.10B$ 6.86B$ 5.91B
$ 19.36B$ 13.12B$ 12.53B$ 10.73B$ 10.33B

Currency in CNY

Innovent Biologics Debt to Assets

015B30B45B0 %60 %120 %180 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets